Backs FY22 revenue view $28.5B-$29B, consensus $28.62B. Backs FY22 tax rate 13%-14%. Backs FY22 gross margin 78%. The company said, "The company reaffirmed its 2022 financial guidance on both a reported and non-GAAP basis."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LLY:
- LLY’s FY23 Guidance Below Estimates
- Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
- Eli Lilly oncology unit announces updated data from BRUIN trial
- Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend
- Eli Lilly increases dividend 15% to $1.13 per share